Clinical Trial

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2025 (before its estimated December 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-10; most recent amendment 2025-01-17.
Status change: Not Yet Recruiting → Recruiting 2023-06-20
Trial Details
NCT Number NCT05855421
Lead Sponsor Universidade do Sul de Santa Catarina
Collaborators: University of Sao Paulo
Conditions Depressive Symptoms, Depression, Anxiety, Insomnia, Quality of Life
Enrollment 280 participants
Start Date 2023-03-01
Primary Completion 2025-12-15 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-20